Please use this identifier to cite or link to this item:
Title: Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis
Authors: Abi Chahine, Nassim
Wehbe, Tarek
Rashed, Johny
Hilal, Ramzi
Elias, Nada
Affiliations: Faculty of Arts and Sciences 
Keywords: Autologous bone marrow
Mononuclear cells
Multiple Sclerosis
Stem cells
The expanded disability status scale
Issue Date: 2016-11-30
Publisher: National Library of Medicine
Part of: International Journal of Stem Cells
Volume: 9
Issue: 2
Start page: 207
End page: 212
Stem cell therapy, an evolving, progressive field of therapeutics has shown several successes in areas where classic treatments failed to prevent or stop disability. Starting in 2009, twenty two sequential patients with progressive Multiple Sclerosis (MS) courses were treated with Autologous Bone Marrow Mononuclear stem cells (BM-MNSCs). The cells were given both intravenously and intrathecally. Using the Expanded Disability Status Scale (EDSS) score for evaluation, our data indicates that the majority of the patients benefited on the average one point on the scale. This paper adds to the body of evidence suggesting the safety and efficacy of autologous BM-MNSCs in the treatment of MS and awaits validation through larger, randomized studies.
ISSN: 2005-3606
DOI: 10.15283/ijsc16049
Open URL: Link to full text
Type: Journal Article
Appears in Collections:Department of Biology

Show full item record


checked on Dec 3, 2022

Record view(s)

checked on Dec 6, 2022

Google ScholarTM


Dimensions Altmetric

Dimensions Altmetric

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.